2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 7.214.981 | 11.447.827 | 3.178.669 | 4.904.834 | 2.977.968 | 4.067.384 | 2.986.100 | 2.740.520 | 4.105.144 | 7.073.394 |
Total Income - EUR | 7.262.871 | 11.606.535 | 3.262.058 | 4.950.874 | 3.018.853 | 4.107.693 | 3.024.368 | 2.762.150 | 4.180.676 | 7.175.500 |
Total Expenses - EUR | 6.689.868 | 11.166.350 | 3.152.936 | 4.610.445 | 2.958.697 | 3.867.453 | 2.788.916 | 2.578.534 | 3.917.851 | 6.543.267 |
Gross Profit/Loss - EUR | 573.003 | 440.185 | 109.122 | 340.429 | 60.156 | 240.240 | 235.452 | 183.616 | 262.826 | 632.233 |
Net Profit/Loss - EUR | 481.793 | 335.374 | 77.952 | 295.967 | 46.687 | 207.642 | 198.282 | 158.967 | 229.238 | 543.554 |
Employees | 31 | 33 | 32 | 30 | 27 | 26 | 23 | 24 | 25 | 26 |
Check the financial reports for the company - Ronexprim Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 548.185 | 530.251 | 493.031 | 481.181 | 439.819 | 452.116 | 435.984 | 398.744 | 372.080 | 352.959 |
Current Assets | 6.292.243 | 6.816.545 | 3.281.584 | 3.134.786 | 2.967.011 | 1.904.516 | 2.010.790 | 1.584.419 | 3.261.314 | 5.374.283 |
Inventories | 3.485.755 | 447.557 | 402.772 | 429.932 | 429.422 | 268.952 | 197.740 | 154.328 | 836.380 | 1.755.881 |
Receivables | 862.107 | 894.682 | 963.722 | 549.670 | 454.912 | 525.099 | 480.188 | 311.199 | 1.904.037 | 744.812 |
Cash | 1.941.926 | 5.471.829 | 1.724.499 | 1.965.682 | 1.896.652 | 928.044 | 1.153.899 | 943.898 | 431.060 | 2.873.590 |
Shareholders Funds | 2.524.066 | 2.748.654 | 2.504.356 | 2.580.207 | 2.261.117 | 1.794.741 | 1.958.999 | 1.579.470 | 553.887 | 1.095.762 |
Social Capital | 26.996 | 27.222 | 26.944 | 26.488 | 26.002 | 25.498 | 25.015 | 24.460 | 24.536 | 24.462 |
Debts | 4.269.790 | 4.440.047 | 1.239.868 | 977.048 | 1.058.773 | 488.068 | 427.464 | 374.556 | 3.011.897 | 4.490.481 |
Income in Advance | 69.086 | 173.953 | 147.176 | 39.392 | 59.076 | 52.125 | 42.975 | 16.321 | 51.412 | 120.694 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4669 - 4669" | |||||||||
CAEN Financial Year |
4669
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Ronexprim Srl